These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 23611920)
21. Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease. Eker S; Ayaz L; Tamer L; Ulubas B Scand J Clin Lab Invest; 2010 Feb; 70(1):40-4. PubMed ID: 20021311 [TBL] [Abstract][Full Text] [Related]
22. Association of plasma netrin-1 level with inflammatory balance and comorbidities in patients with acute exacerbation of COPD. Kerget B; Afşin DE; Kerget F; Koçak AO; Aksakal A; Kızıltunç A; Araz Ö; Yılmazel Uçar E; Akgün M Tuberk Toraks; 2021 Mar; 69(1):30-38. PubMed ID: 33853303 [TBL] [Abstract][Full Text] [Related]
23. Proteoglycan 4 is a diagnostic biomarker for COPD. Lee KY; Chuang HC; Chen TT; Liu WT; Su CL; Feng PH; Chiang LL; Bien MY; Ho SC Int J Chron Obstruct Pulmon Dis; 2015; 10():1999-2007. PubMed ID: 26451097 [TBL] [Abstract][Full Text] [Related]
24. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients. Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227 [TBL] [Abstract][Full Text] [Related]
25. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation. Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328 [TBL] [Abstract][Full Text] [Related]
26. IL-26 in the induced sputum is associated with the level of systemic inflammation, lung functions and body weight in COPD patients. Savchenko L; Mykytiuk M; Cinato M; Tronchere H; Kunduzova O; Kaidashev I Int J Chron Obstruct Pulmon Dis; 2018; 13():2569-2575. PubMed ID: 30197513 [TBL] [Abstract][Full Text] [Related]
27. Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease. Kythreotis P; Kokkini A; Avgeropoulou S; Hadjioannou A; Anastasakou E; Rasidakis A; Bakakos P BMC Pulm Med; 2009 Apr; 9():11. PubMed ID: 19344528 [TBL] [Abstract][Full Text] [Related]
28. Leptin, resistin and fetuin a concentration as the potential useful biomarkers in stable COPD - An exploratory study. Małujło-Balcerska E; Kumor-Kisielewska A; Śmigielski W Cytokine; 2023 Sep; 169():156275. PubMed ID: 37354646 [TBL] [Abstract][Full Text] [Related]
29. Associations between BODE index and systemic inflammatory biomarkers in COPD. Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400 [TBL] [Abstract][Full Text] [Related]
30. Airway bacterial colonization and serum C-reactive protein are associated with chronic obstructive pulmonary disease exacerbation following bronchoscopic lung volume reduction. Fruchter O; Rosengarten D; Goldberg E; Ben-Zvi H; Tor R; Kramer MR Clin Respir J; 2016 Mar; 10(2):239-45. PubMed ID: 25196428 [TBL] [Abstract][Full Text] [Related]
31. [Circulating leptin and ghrelin in patients with chronic obstructive pulmonary disease]. Peng M; Cai BQ; Ma Y; Zhu HJ; Sun Q; Song AL Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):182-5. PubMed ID: 17572996 [TBL] [Abstract][Full Text] [Related]
32. Systemic inflammation in patients with COPD and pulmonary hypertension. Joppa P; Petrasova D; Stancak B; Tkacova R Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829 [TBL] [Abstract][Full Text] [Related]
33. Relationship of leptin with adiposity and inflammation and resistin with disease severity in psoriatic patients undergoing anti-TNF-alpha therapy. Pina T; Genre F; Lopez-Mejias R; Armesto S; Ubilla B; Mijares V; Dierssen-Sotos T; Gonzalez-Lopez MA; Gonzalez-Vela MC; Blanco R; Hernández JL; Llorca J; Gonzalez-Gay MA J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1995-2001. PubMed ID: 25823684 [TBL] [Abstract][Full Text] [Related]
34. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study. Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664 [TBL] [Abstract][Full Text] [Related]
35. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413 [TBL] [Abstract][Full Text] [Related]
36. [Serum myostatin levels and malnutrition in patients with chronic obstructive pulmonary disease]. Ju CR; Chen RC Zhonghua Nei Ke Za Zhi; 2011 Jun; 50(6):465-8. PubMed ID: 21781527 [TBL] [Abstract][Full Text] [Related]
37. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients]. Xiao W; Tong WL; Ma DD Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049 [TBL] [Abstract][Full Text] [Related]
38. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779 [TBL] [Abstract][Full Text] [Related]
39. C-reactive protein levels in stable COPD patients: a case-control study. Silva DR; Gazzana MB; Knorst MM Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470 [TBL] [Abstract][Full Text] [Related]
40. Serum angiopoietin-like 4 is over-expressed in COPD patients: association with pulmonary function and inflammation. Wu YQ; Shen YC; Wang H; Zhang JL; Li DD; Zhang X; Wang T; Xu D; Ying BW; Wang LL; Wen FQ Eur Rev Med Pharmacol Sci; 2016; 20(1):44-53. PubMed ID: 26813452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]